cb 2 receptors Search Results


90
OriGene cb2r
Newly synthesized cannabinoids and the cAMP assay screening for cannabinoid receptor modulators. (A) The structure of α-oleoyl oleoylamine ethanolamine (α-OOE) and α-oleoyl oleoylamine serinol (α-OOS). (B, C) Synthetic compounds were screened in stable CHO cell lines overexpressing cannabinoid receptor-1 (CB1R) or <t>CB2R.</t> Pre-treatment with CBR agonists significantly diminished the cytosolic levels of cAMP induced by 10 µM forskolin (B). N-arachidonoylethanolamine (AEA) and Hu308 were used as controls for CB1R and CB2R, respectively. All data are presented as the mean±standard error, t -test and analysis of variance. * p <0.01.
Cb2r, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cb+2+receptors/pmc04737832-33-17-22?v=OriGene
Average 90 stars, based on 1 article reviews
cb2r - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
OriGene cnr2
Newly synthesized cannabinoids and the cAMP assay screening for cannabinoid receptor modulators. (A) The structure of α-oleoyl oleoylamine ethanolamine (α-OOE) and α-oleoyl oleoylamine serinol (α-OOS). (B, C) Synthetic compounds were screened in stable CHO cell lines overexpressing cannabinoid receptor-1 (CB1R) or <t>CB2R.</t> Pre-treatment with CBR agonists significantly diminished the cytosolic levels of cAMP induced by 10 µM forskolin (B). N-arachidonoylethanolamine (AEA) and Hu308 were used as controls for CB1R and CB2R, respectively. All data are presented as the mean±standard error, t -test and analysis of variance. * p <0.01.
Cnr2, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cb+2+receptors/pmc02865327-267-17-24?v=OriGene
Average 90 stars, based on 1 article reviews
cnr2 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

92
Alomone Labs acr
Newly synthesized cannabinoids and the cAMP assay screening for cannabinoid receptor modulators. (A) The structure of α-oleoyl oleoylamine ethanolamine (α-OOE) and α-oleoyl oleoylamine serinol (α-OOS). (B, C) Synthetic compounds were screened in stable CHO cell lines overexpressing cannabinoid receptor-1 (CB1R) or <t>CB2R.</t> Pre-treatment with CBR agonists significantly diminished the cytosolic levels of cAMP induced by 10 µM forskolin (B). N-arachidonoylethanolamine (AEA) and Hu308 were used as controls for CB1R and CB2R, respectively. All data are presented as the mean±standard error, t -test and analysis of variance. * p <0.01.
Acr, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cb+2+receptors/pmc07959141-30-14-9?v=Alomone+Labs
Average 92 stars, based on 1 article reviews
acr - by Bioz Stars, 2026-08
92/100 stars
  Buy from Supplier

90
Boster Bio cb2
β‐catenin signalling is inhibited by <t>CB2</t> gene ablation in d ‐gal‐treated mice. (A) Experimental design. Black bar indicated that mice were administered subcutaneous injections of d ‐gal at 150mg/kg/day for 6 weeks after surgery for 1 week. UNX: unilateral nephrectomy. (B) Representative micrographs showing renal expression of CB2 in different groups. Cryosections were subjected to fluorescence in situ hybridization (FISH) staining for CB2. Arrow indicates positive staining. scale bar, 25 μm. (C) Quantitative real‐time PCR results showing renal expression of CB2. * p < 0.05 versus WT mice group alone; ## p < 0.01 versus the d ‐gal‐treated WT mice group alone (n = 5–6). (D and E) Representative Western blot and quantitative data showing renal expression of β‐catenin. Numbers (1–3) indicate each individual animal in a given group. *** p < 0.001 versus WT mice group alone; ### p < 0.001 versus the d ‐gal‐treated WT mice group alone (n = 5–6). (F and G) Quantitative real‐time PCR results showing renal expression of MMP7 and AT1. * p < 0.05 and *** p < 0.001 versus WT mice group alone; # p < 0.05 and ## p < 0.01 versus the d ‐gal‐treated WT mice group alone (n = 5–6). (H) Representative micrographs showing the expression of active β‐catenin. Frozen kidney sections were stained with an antibody against active β‐catenin. Arrow indicates positive staining. Scale bar, 75μm. (I) Quantitative data showing quantification of positive staining. * p < 0.05 versus WT mice group alone; # p < 0.05 versus the d ‐gal‐treated WT mice group alone (n = 5–6)
Cb2, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cb+2+receptors/pmc08435409-68-3-17?v=Boster+Bio
Average 90 stars, based on 1 article reviews
cb2 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

93
Alomone Labs rabbit polyclonal anti cb 2
Effect of ZnONPs on aorta contractility. ( a ) Effect of ACPA (CB 1 receptor agonist) on contraction in aortic rings in different experimental groups. ( b ) Effect of HU308 (CB 2 receptor agonist) on contraction in aortic rings in different experimental groups. Blue bars correspond to the control non-treated group, green bars correspond to the ZnONPs treated-groups at different times; ( a ) there is a significant difference compared to the phenylephrine group with p < 0.05; ( b ) there is a significant difference compared to the control group with p < 0.05.
Rabbit Polyclonal Anti Cb 2, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cb+2+receptors/pmc08472382-64-28-33?v=Alomone+Labs
Average 93 stars, based on 1 article reviews
rabbit polyclonal anti cb 2 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

90
Cayman Chemical residues 20–33 human/mouse cb2 receptor
Effect of ZnONPs on aorta contractility. ( a ) Effect of ACPA (CB 1 receptor agonist) on contraction in aortic rings in different experimental groups. ( b ) Effect of HU308 (CB 2 receptor agonist) on contraction in aortic rings in different experimental groups. Blue bars correspond to the control non-treated group, green bars correspond to the ZnONPs treated-groups at different times; ( a ) there is a significant difference compared to the phenylephrine group with p < 0.05; ( b ) there is a significant difference compared to the control group with p < 0.05.
Residues 20–33 Human/Mouse Cb2 Receptor, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cb+2+receptors/pm12511587-83-38-46?v=Cayman+Chemical
Average 90 stars, based on 1 article reviews
residues 20–33 human/mouse cb2 receptor - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
MyBiosource Biotechnology antibody against cb2 receptor
Effect of ZnONPs on aorta contractility. ( a ) Effect of ACPA (CB 1 receptor agonist) on contraction in aortic rings in different experimental groups. ( b ) Effect of HU308 (CB 2 receptor agonist) on contraction in aortic rings in different experimental groups. Blue bars correspond to the control non-treated group, green bars correspond to the ZnONPs treated-groups at different times; ( a ) there is a significant difference compared to the phenylephrine group with p < 0.05; ( b ) there is a significant difference compared to the control group with p < 0.05.
Antibody Against Cb2 Receptor, supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cb+2+receptors/pmc05248520-65-38-53?v=MyBiosource+Biotechnology
Average 90 stars, based on 1 article reviews
antibody against cb2 receptor - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
FUJIFILM am630
Δ 9 -THC toxicity in HL-1 cells involves cytoplasmic vacuolization. (A) Δ 9 -THC and/or ethanol decreases cell viability. HL-1 cells were treated with the indicated concentrations of Δ 9 -THC and/or ethanol for 48 h. Cellular viabilities were determined by modified MTT assay. Mean cell viability of control cells [Δ 9 -THC (-), ethanol (-)] was set to 100 %, and relative cell viabilities of Δ 9 -THC and/or ethanol treated cells are shown [mean ± S.D. (n = 6); **, p < 0.01]. (B) Cells were treated with the indicated concentrations of Δ 9 -THC and/or ethanol for 48 h and observed under light microscopy. (C) Δ 9 -THC toxicity is not ameliorated by CB-R1/2 antagonists. Cells were pretreated with 1 μM <t>AM630</t> or 1 μM AM251 for 1 h and further treated with the indicated concentrations of Δ 9 -THC and/or ethanol for 48 h. Graph shows the result of modified MTT assay [mean ± S.D. (n = 6); **, p < 0.01 versus untreated group].
Am630, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cb+2+receptors/pmc08131391-49-3-7?v=FUJIFILM
Average 90 stars, based on 1 article reviews
am630 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Cayman Chemical primary antibodies against the cb2 receptor
Δ 9 -THC toxicity in HL-1 cells involves cytoplasmic vacuolization. (A) Δ 9 -THC and/or ethanol decreases cell viability. HL-1 cells were treated with the indicated concentrations of Δ 9 -THC and/or ethanol for 48 h. Cellular viabilities were determined by modified MTT assay. Mean cell viability of control cells [Δ 9 -THC (-), ethanol (-)] was set to 100 %, and relative cell viabilities of Δ 9 -THC and/or ethanol treated cells are shown [mean ± S.D. (n = 6); **, p < 0.01]. (B) Cells were treated with the indicated concentrations of Δ 9 -THC and/or ethanol for 48 h and observed under light microscopy. (C) Δ 9 -THC toxicity is not ameliorated by CB-R1/2 antagonists. Cells were pretreated with 1 μM <t>AM630</t> or 1 μM AM251 for 1 h and further treated with the indicated concentrations of Δ 9 -THC and/or ethanol for 48 h. Graph shows the result of modified MTT assay [mean ± S.D. (n = 6); **, p < 0.01 versus untreated group].
Primary Antibodies Against The Cb2 Receptor, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cb+2+receptors/pm25975960-73-12-18?v=Cayman+Chemical
Average 90 stars, based on 1 article reviews
primary antibodies against the cb2 receptor - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
BioSignal Group human cb2 receptor
Δ 9 -THC toxicity in HL-1 cells involves cytoplasmic vacuolization. (A) Δ 9 -THC and/or ethanol decreases cell viability. HL-1 cells were treated with the indicated concentrations of Δ 9 -THC and/or ethanol for 48 h. Cellular viabilities were determined by modified MTT assay. Mean cell viability of control cells [Δ 9 -THC (-), ethanol (-)] was set to 100 %, and relative cell viabilities of Δ 9 -THC and/or ethanol treated cells are shown [mean ± S.D. (n = 6); **, p < 0.01]. (B) Cells were treated with the indicated concentrations of Δ 9 -THC and/or ethanol for 48 h and observed under light microscopy. (C) Δ 9 -THC toxicity is not ameliorated by CB-R1/2 antagonists. Cells were pretreated with 1 μM <t>AM630</t> or 1 μM AM251 for 1 h and further treated with the indicated concentrations of Δ 9 -THC and/or ethanol for 48 h. Graph shows the result of modified MTT assay [mean ± S.D. (n = 6); **, p < 0.01 versus untreated group].
Human Cb2 Receptor, supplied by BioSignal Group, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cb+2+receptors/us07517898-153-15-19?v=BioSignal+Group
Average 90 stars, based on 1 article reviews
human cb2 receptor - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Rorer Inc cb 1 /cb 2 receptor agonist cp55,940
Δ 9 -THC toxicity in HL-1 cells involves cytoplasmic vacuolization. (A) Δ 9 -THC and/or ethanol decreases cell viability. HL-1 cells were treated with the indicated concentrations of Δ 9 -THC and/or ethanol for 48 h. Cellular viabilities were determined by modified MTT assay. Mean cell viability of control cells [Δ 9 -THC (-), ethanol (-)] was set to 100 %, and relative cell viabilities of Δ 9 -THC and/or ethanol treated cells are shown [mean ± S.D. (n = 6); **, p < 0.01]. (B) Cells were treated with the indicated concentrations of Δ 9 -THC and/or ethanol for 48 h and observed under light microscopy. (C) Δ 9 -THC toxicity is not ameliorated by CB-R1/2 antagonists. Cells were pretreated with 1 μM <t>AM630</t> or 1 μM AM251 for 1 h and further treated with the indicated concentrations of Δ 9 -THC and/or ethanol for 48 h. Graph shows the result of modified MTT assay [mean ± S.D. (n = 6); **, p < 0.01 versus untreated group].
Cb 1 /Cb 2 Receptor Agonist Cp55,940, supplied by Rorer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cb+2+receptors/pmc01572241-97-1-24?v=Rorer+Inc
Average 90 stars, based on 1 article reviews
cb 1 /cb 2 receptor agonist cp55,940 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
GenScript corporation human cannabinoid receptor cb2 coding sequence
Δ 9 -THC toxicity in HL-1 cells involves cytoplasmic vacuolization. (A) Δ 9 -THC and/or ethanol decreases cell viability. HL-1 cells were treated with the indicated concentrations of Δ 9 -THC and/or ethanol for 48 h. Cellular viabilities were determined by modified MTT assay. Mean cell viability of control cells [Δ 9 -THC (-), ethanol (-)] was set to 100 %, and relative cell viabilities of Δ 9 -THC and/or ethanol treated cells are shown [mean ± S.D. (n = 6); **, p < 0.01]. (B) Cells were treated with the indicated concentrations of Δ 9 -THC and/or ethanol for 48 h and observed under light microscopy. (C) Δ 9 -THC toxicity is not ameliorated by CB-R1/2 antagonists. Cells were pretreated with 1 μM <t>AM630</t> or 1 μM AM251 for 1 h and further treated with the indicated concentrations of Δ 9 -THC and/or ethanol for 48 h. Graph shows the result of modified MTT assay [mean ± S.D. (n = 6); **, p < 0.01 versus untreated group].
Human Cannabinoid Receptor Cb2 Coding Sequence, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cb+2+receptors/pmc10581484-95-1-14?v=GenScript+corporation
Average 90 stars, based on 1 article reviews
human cannabinoid receptor cb2 coding sequence - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Newly synthesized cannabinoids and the cAMP assay screening for cannabinoid receptor modulators. (A) The structure of α-oleoyl oleoylamine ethanolamine (α-OOE) and α-oleoyl oleoylamine serinol (α-OOS). (B, C) Synthetic compounds were screened in stable CHO cell lines overexpressing cannabinoid receptor-1 (CB1R) or CB2R. Pre-treatment with CBR agonists significantly diminished the cytosolic levels of cAMP induced by 10 µM forskolin (B). N-arachidonoylethanolamine (AEA) and Hu308 were used as controls for CB1R and CB2R, respectively. All data are presented as the mean±standard error, t -test and analysis of variance. * p <0.01.

Journal: Annals of Dermatology

Article Title: Selective Cannabinoid Receptor-1 Agonists Regulate Mast Cell Activation in an Oxazolone-Induced Atopic Dermatitis Model

doi: 10.5021/ad.2016.28.1.22

Figure Lengend Snippet: Newly synthesized cannabinoids and the cAMP assay screening for cannabinoid receptor modulators. (A) The structure of α-oleoyl oleoylamine ethanolamine (α-OOE) and α-oleoyl oleoylamine serinol (α-OOS). (B, C) Synthetic compounds were screened in stable CHO cell lines overexpressing cannabinoid receptor-1 (CB1R) or CB2R. Pre-treatment with CBR agonists significantly diminished the cytosolic levels of cAMP induced by 10 µM forskolin (B). N-arachidonoylethanolamine (AEA) and Hu308 were used as controls for CB1R and CB2R, respectively. All data are presented as the mean±standard error, t -test and analysis of variance. * p <0.01.

Article Snippet: To establish stable cell lines expressing CBR, CHO-K1 cells were transfected with human CB1R (Cat. RC210397) and CB2R (Cat. SC118984) cDNA constructs (Origene, Rockville, MD, USA); the following day, media were replaced with F12 standard medium containing G418 (100 μg/ml) to select for stable clones.

Techniques: Synthesized, cAMP Assay

β‐catenin signalling is inhibited by CB2 gene ablation in d ‐gal‐treated mice. (A) Experimental design. Black bar indicated that mice were administered subcutaneous injections of d ‐gal at 150mg/kg/day for 6 weeks after surgery for 1 week. UNX: unilateral nephrectomy. (B) Representative micrographs showing renal expression of CB2 in different groups. Cryosections were subjected to fluorescence in situ hybridization (FISH) staining for CB2. Arrow indicates positive staining. scale bar, 25 μm. (C) Quantitative real‐time PCR results showing renal expression of CB2. * p < 0.05 versus WT mice group alone; ## p < 0.01 versus the d ‐gal‐treated WT mice group alone (n = 5–6). (D and E) Representative Western blot and quantitative data showing renal expression of β‐catenin. Numbers (1–3) indicate each individual animal in a given group. *** p < 0.001 versus WT mice group alone; ### p < 0.001 versus the d ‐gal‐treated WT mice group alone (n = 5–6). (F and G) Quantitative real‐time PCR results showing renal expression of MMP7 and AT1. * p < 0.05 and *** p < 0.001 versus WT mice group alone; # p < 0.05 and ## p < 0.01 versus the d ‐gal‐treated WT mice group alone (n = 5–6). (H) Representative micrographs showing the expression of active β‐catenin. Frozen kidney sections were stained with an antibody against active β‐catenin. Arrow indicates positive staining. Scale bar, 75μm. (I) Quantitative data showing quantification of positive staining. * p < 0.05 versus WT mice group alone; # p < 0.05 versus the d ‐gal‐treated WT mice group alone (n = 5–6)

Journal: Journal of Cellular and Molecular Medicine

Article Title: Cannabinoid receptor 2 plays a central role in renal tubular mitochondrial dysfunction and kidney ageing

doi: 10.1111/jcmm.16857

Figure Lengend Snippet: β‐catenin signalling is inhibited by CB2 gene ablation in d ‐gal‐treated mice. (A) Experimental design. Black bar indicated that mice were administered subcutaneous injections of d ‐gal at 150mg/kg/day for 6 weeks after surgery for 1 week. UNX: unilateral nephrectomy. (B) Representative micrographs showing renal expression of CB2 in different groups. Cryosections were subjected to fluorescence in situ hybridization (FISH) staining for CB2. Arrow indicates positive staining. scale bar, 25 μm. (C) Quantitative real‐time PCR results showing renal expression of CB2. * p < 0.05 versus WT mice group alone; ## p < 0.01 versus the d ‐gal‐treated WT mice group alone (n = 5–6). (D and E) Representative Western blot and quantitative data showing renal expression of β‐catenin. Numbers (1–3) indicate each individual animal in a given group. *** p < 0.001 versus WT mice group alone; ### p < 0.001 versus the d ‐gal‐treated WT mice group alone (n = 5–6). (F and G) Quantitative real‐time PCR results showing renal expression of MMP7 and AT1. * p < 0.05 and *** p < 0.001 versus WT mice group alone; # p < 0.05 and ## p < 0.01 versus the d ‐gal‐treated WT mice group alone (n = 5–6). (H) Representative micrographs showing the expression of active β‐catenin. Frozen kidney sections were stained with an antibody against active β‐catenin. Arrow indicates positive staining. Scale bar, 75μm. (I) Quantitative data showing quantification of positive staining. * p < 0.05 versus WT mice group alone; # p < 0.05 versus the d ‐gal‐treated WT mice group alone (n = 5–6)

Article Snippet: The expression of CB2 was assayed by fluorescence staining using a Fluorescence in situ hybridization kit (MK2530‐m; Boster technology).

Techniques: Expressing, Fluorescence, In Situ Hybridization, Staining, Real-time Polymerase Chain Reaction, Western Blot

CB2 is upregulated in aged kidneys. (A) Representative micrographs showing CB2 expression in kidneys from 2‐month‐old and 24‐month‐old mice. Cryosections were subjected to fluorescence in situ hybridization (FISH) staining for CB2. Arrow indicates positive staining. scale bar, 25 μm. (B‐E) Representative Western blot and quantitative data showing renal expression of CB2 from 2‐month‐old and 24‐month‐old mice (B and C) or mice which were administered subcutaneous injections of d ‐gal at 150mg/kg/day for 6 weeks (D and E). Numbers (1–5) indicate each individual animal in a given group. ** p < 0.01 versus 2‐month‐old mice group or the sham control group (n = 5). (F) Representative images showing renal expression of CB2 in d ‐gal‐treated mice. Cryosections were subjected to fluorescence in situ hybridization (FISH) staining for CB2. Arrow indicates positive staining. scale bar, 25 μm. (G) Representative micrographs showing the colocalization of CB2 and various segment‐specific tubular markers in kidneys. Frozen kidney sections were stained for CB2 (red) using FISH and various segment‐specific tubular markers (green) by immunofluorescence. The following segment‐specific tubular markers were used: proximal tubule, lotus tetragonolobus lectin (LTL); distal tubule, peanut agglutinin (PNA); arrows indicate positive tubules with colocalization of CB2 and specific tubular markers. Scale bar, 25 μm. (H) Representative micrographs showing the expression of CB2 and TOMM20 in tubules in 2‐month‐old and 24‐month‐old mice. Cryosections were subjected to FISH staining of CB2 (red) and stained with TOMM20 (green) antibody by immunofluorescence. Arrows indicate positive staining. Scale bar, 25μm

Journal: Journal of Cellular and Molecular Medicine

Article Title: Cannabinoid receptor 2 plays a central role in renal tubular mitochondrial dysfunction and kidney ageing

doi: 10.1111/jcmm.16857

Figure Lengend Snippet: CB2 is upregulated in aged kidneys. (A) Representative micrographs showing CB2 expression in kidneys from 2‐month‐old and 24‐month‐old mice. Cryosections were subjected to fluorescence in situ hybridization (FISH) staining for CB2. Arrow indicates positive staining. scale bar, 25 μm. (B‐E) Representative Western blot and quantitative data showing renal expression of CB2 from 2‐month‐old and 24‐month‐old mice (B and C) or mice which were administered subcutaneous injections of d ‐gal at 150mg/kg/day for 6 weeks (D and E). Numbers (1–5) indicate each individual animal in a given group. ** p < 0.01 versus 2‐month‐old mice group or the sham control group (n = 5). (F) Representative images showing renal expression of CB2 in d ‐gal‐treated mice. Cryosections were subjected to fluorescence in situ hybridization (FISH) staining for CB2. Arrow indicates positive staining. scale bar, 25 μm. (G) Representative micrographs showing the colocalization of CB2 and various segment‐specific tubular markers in kidneys. Frozen kidney sections were stained for CB2 (red) using FISH and various segment‐specific tubular markers (green) by immunofluorescence. The following segment‐specific tubular markers were used: proximal tubule, lotus tetragonolobus lectin (LTL); distal tubule, peanut agglutinin (PNA); arrows indicate positive tubules with colocalization of CB2 and specific tubular markers. Scale bar, 25 μm. (H) Representative micrographs showing the expression of CB2 and TOMM20 in tubules in 2‐month‐old and 24‐month‐old mice. Cryosections were subjected to FISH staining of CB2 (red) and stained with TOMM20 (green) antibody by immunofluorescence. Arrows indicate positive staining. Scale bar, 25μm

Article Snippet: The expression of CB2 was assayed by fluorescence staining using a Fluorescence in situ hybridization kit (MK2530‐m; Boster technology).

Techniques: Expressing, Fluorescence, In Situ Hybridization, Staining, Western Blot, Control, Immunofluorescence

CB2 gene ablation does not affect kidney ageing or mitochondrial function in young mice. (A) RT‐PCR analyses showing renal expression of CB2 in wild‐type mice (WT) and CB2 knockout mice (KO). Numbers (1–4) indicate each individual animal in a given group. (B‐F) Quantitative real‐time PCR results showing renal expression of CB2, fibronectin, α‐SMA, CollagenⅠa1 and CollagenⅢa1 in WT and KO mice. ** p < 0.01, n.s. versus WT mice group (n = 4). n.s.: no significance. (G) Representative micrographs showing Periodic acid‐Schiff (PAS) staining, Sirius red staining, senescence‐associated β‐galactosidase activity (SA‐β‐gal) staining and the expression of TOMM20. Paraffin‐embedded kidney sections were subjected to PAS and Sirius red staining. Frozen kidney sections were stained for SA‐β‐gal activity and TOMM20. Scale bar, 50 μm. (H‐K) Representative Western blot and quantitative data showing renal expression of PGC‐1α, TOMM20 and TFAM in WT and KO mice. Numbers (1–4) indicate each individual animal in a given group. n.s. versus WT mice group (n=4). n.s.: no significance. (L‐M) Quantitative real‐time PCR results showing renal expression of p16 INK4A and γH2AX in WT and KO mice. n.s. versus WT mice group (n = 4). n.s.: no significance. (N‐R) Representative Western blot and quantitative data showing renal expression of β‐catenin, MMP7, Snail1 and AT1 in WT and KO mice. Numbers (1–4) indicate each individual animal in a given group. n.s. versus WT mice group (n = 4). n.s.: no significance

Journal: Journal of Cellular and Molecular Medicine

Article Title: Cannabinoid receptor 2 plays a central role in renal tubular mitochondrial dysfunction and kidney ageing

doi: 10.1111/jcmm.16857

Figure Lengend Snippet: CB2 gene ablation does not affect kidney ageing or mitochondrial function in young mice. (A) RT‐PCR analyses showing renal expression of CB2 in wild‐type mice (WT) and CB2 knockout mice (KO). Numbers (1–4) indicate each individual animal in a given group. (B‐F) Quantitative real‐time PCR results showing renal expression of CB2, fibronectin, α‐SMA, CollagenⅠa1 and CollagenⅢa1 in WT and KO mice. ** p < 0.01, n.s. versus WT mice group (n = 4). n.s.: no significance. (G) Representative micrographs showing Periodic acid‐Schiff (PAS) staining, Sirius red staining, senescence‐associated β‐galactosidase activity (SA‐β‐gal) staining and the expression of TOMM20. Paraffin‐embedded kidney sections were subjected to PAS and Sirius red staining. Frozen kidney sections were stained for SA‐β‐gal activity and TOMM20. Scale bar, 50 μm. (H‐K) Representative Western blot and quantitative data showing renal expression of PGC‐1α, TOMM20 and TFAM in WT and KO mice. Numbers (1–4) indicate each individual animal in a given group. n.s. versus WT mice group (n=4). n.s.: no significance. (L‐M) Quantitative real‐time PCR results showing renal expression of p16 INK4A and γH2AX in WT and KO mice. n.s. versus WT mice group (n = 4). n.s.: no significance. (N‐R) Representative Western blot and quantitative data showing renal expression of β‐catenin, MMP7, Snail1 and AT1 in WT and KO mice. Numbers (1–4) indicate each individual animal in a given group. n.s. versus WT mice group (n = 4). n.s.: no significance

Article Snippet: The expression of CB2 was assayed by fluorescence staining using a Fluorescence in situ hybridization kit (MK2530‐m; Boster technology).

Techniques: Reverse Transcription Polymerase Chain Reaction, Expressing, Knock-Out, Real-time Polymerase Chain Reaction, Staining, Activity Assay, Western Blot

CB2 deficiency protects renal mitochondrial homeostasis in the accelerated ageing mice. (A) Representative micrographs showing renal expression of PGC‐1α and TOMM20 in different groups. Paraffin‐embedded kidney sections were immunostained with an antibody against PGC‐1α or TOMM20. Arrows indicate positive staining. Scale bar, 50 μm. (B‐C) Quantitative data showing quantification of positive staining. * p < 0.05, *** p < 0.001 versus WT mice group alone; # p < 0.05, ### p < 0.001 versus the d ‐gal‐treated WT mice group alone (n = 5–6). (D) Representative graph showing the production of adenosine triphosphate (ATP) in different groups. * p < 0.05 versus WT mice group alone; ## p < 0.01 versus the d ‐gal‐treated WT mice group alone (n = 5–6). (E–H) Representative Western blot and quantitative data showing renal expression of PGC‐1α, TOMM20 and Cytb. Numbers (1–3) indicate each individual animal in a given group. * p < 0.05, ** p < 0.01, *** p < 0.001 versus the WT mice group alone; # p < 0.05, ### p < 0.001 versus the d ‐gal‐treated WT mice group alone (n = 5–6). (I) Representative transmission electron microscopy graphs showing mitochondrial ultrastructure of renal tubular cells in different groups. Arrows indicate damaged and abnormal‐shaped mitochondria. Scale bar, 1μm

Journal: Journal of Cellular and Molecular Medicine

Article Title: Cannabinoid receptor 2 plays a central role in renal tubular mitochondrial dysfunction and kidney ageing

doi: 10.1111/jcmm.16857

Figure Lengend Snippet: CB2 deficiency protects renal mitochondrial homeostasis in the accelerated ageing mice. (A) Representative micrographs showing renal expression of PGC‐1α and TOMM20 in different groups. Paraffin‐embedded kidney sections were immunostained with an antibody against PGC‐1α or TOMM20. Arrows indicate positive staining. Scale bar, 50 μm. (B‐C) Quantitative data showing quantification of positive staining. * p < 0.05, *** p < 0.001 versus WT mice group alone; # p < 0.05, ### p < 0.001 versus the d ‐gal‐treated WT mice group alone (n = 5–6). (D) Representative graph showing the production of adenosine triphosphate (ATP) in different groups. * p < 0.05 versus WT mice group alone; ## p < 0.01 versus the d ‐gal‐treated WT mice group alone (n = 5–6). (E–H) Representative Western blot and quantitative data showing renal expression of PGC‐1α, TOMM20 and Cytb. Numbers (1–3) indicate each individual animal in a given group. * p < 0.05, ** p < 0.01, *** p < 0.001 versus the WT mice group alone; # p < 0.05, ### p < 0.001 versus the d ‐gal‐treated WT mice group alone (n = 5–6). (I) Representative transmission electron microscopy graphs showing mitochondrial ultrastructure of renal tubular cells in different groups. Arrows indicate damaged and abnormal‐shaped mitochondria. Scale bar, 1μm

Article Snippet: The expression of CB2 was assayed by fluorescence staining using a Fluorescence in situ hybridization kit (MK2530‐m; Boster technology).

Techniques: Expressing, Staining, Western Blot, Transmission Assay, Electron Microscopy

CB2 gene ablation ameliorates kidney ageing. (A) Representative micrographs showing renal expression of γH2AX and SA‐β‐gal activity in different groups. Paraffin‐embedded kidney sections were immunostained with an antibody against γH2AX (top). Frozen kidney sections were stained for SA‐β‐gal activity (bottom). Arrows indicate positive staining. Scale bar, 50 μm. (B‐C) Quantitative data showing quantification of positive staining. ** p < 0.01 versus WT mice group alone; ## p < 0.01 versus the d ‐gal‐treated WT mice group alone (n = 5–6). (D–G) Representative Western blot and quantitative data showing renal expression of p16 INK4A , γH2AX and p19 ARF in different groups. Numbers (1–3) indicate each individual animal in a given group. ** p < 0.01, *** p < 0.001 versus the WT mice group alone; # p < 0.05, ## p < 0.01, ### p < 0.001 versus the d ‐gal‐treated WT mice group alone (n = 5–6). (H and I) Representative micrographs showing renal expression of klotho in different groups (H). Paraffin‐embedded kidney sections were immunostained with an antibody against klotho. Arrows indicate positive staining. Scale bar, 50 μm. (I) Quantitative data showing quantification of positive staining. *** p < 0.001 versus the WT mice group alone; ### p < 0.001 versus the d ‐gal‐treated WT mice group alone (n = 5–6)

Journal: Journal of Cellular and Molecular Medicine

Article Title: Cannabinoid receptor 2 plays a central role in renal tubular mitochondrial dysfunction and kidney ageing

doi: 10.1111/jcmm.16857

Figure Lengend Snippet: CB2 gene ablation ameliorates kidney ageing. (A) Representative micrographs showing renal expression of γH2AX and SA‐β‐gal activity in different groups. Paraffin‐embedded kidney sections were immunostained with an antibody against γH2AX (top). Frozen kidney sections were stained for SA‐β‐gal activity (bottom). Arrows indicate positive staining. Scale bar, 50 μm. (B‐C) Quantitative data showing quantification of positive staining. ** p < 0.01 versus WT mice group alone; ## p < 0.01 versus the d ‐gal‐treated WT mice group alone (n = 5–6). (D–G) Representative Western blot and quantitative data showing renal expression of p16 INK4A , γH2AX and p19 ARF in different groups. Numbers (1–3) indicate each individual animal in a given group. ** p < 0.01, *** p < 0.001 versus the WT mice group alone; # p < 0.05, ## p < 0.01, ### p < 0.001 versus the d ‐gal‐treated WT mice group alone (n = 5–6). (H and I) Representative micrographs showing renal expression of klotho in different groups (H). Paraffin‐embedded kidney sections were immunostained with an antibody against klotho. Arrows indicate positive staining. Scale bar, 50 μm. (I) Quantitative data showing quantification of positive staining. *** p < 0.001 versus the WT mice group alone; ### p < 0.001 versus the d ‐gal‐treated WT mice group alone (n = 5–6)

Article Snippet: The expression of CB2 was assayed by fluorescence staining using a Fluorescence in situ hybridization kit (MK2530‐m; Boster technology).

Techniques: Expressing, Activity Assay, Staining, Western Blot

CB2 deficiency retards age‐related kidney fibrosis. (A and B) Quantitative data showing serum creatinine (Scr) and blood urea nitrogen (BUN) levels in different groups. n.s.: no significance. (C–E) Representative Western blot and quantitative data showing renal expression of fibronectin and α‐SMA in different groups. Numbers (1–3) indicate each individual animal in a given group. * p < 0.05 versus the WT mice group alone; # p < 0.05, ## p < 0.01 versus the d ‐gal‐treated WT mice group alone (n = 5–6). (F–H) Representative micrographs showing renal expression of fibronectin and Sirius red staining in different groups. Paraffin‐embedded kidney sections were stained with Sirius red and were immunostained with an antibody against fibronectin. Arrows indicate positive staining. Scale bar, 50 μm. Quantitative data showing quantification of positive staining of fibronectin (G) and fibrotic area (H). ** p < 0.01, *** p < 0.001 versus the WT mice group alone; ## p < 0.01, ### p < 0.001versus the d ‐gal‐treated WT mice group alone (n = 5–6)

Journal: Journal of Cellular and Molecular Medicine

Article Title: Cannabinoid receptor 2 plays a central role in renal tubular mitochondrial dysfunction and kidney ageing

doi: 10.1111/jcmm.16857

Figure Lengend Snippet: CB2 deficiency retards age‐related kidney fibrosis. (A and B) Quantitative data showing serum creatinine (Scr) and blood urea nitrogen (BUN) levels in different groups. n.s.: no significance. (C–E) Representative Western blot and quantitative data showing renal expression of fibronectin and α‐SMA in different groups. Numbers (1–3) indicate each individual animal in a given group. * p < 0.05 versus the WT mice group alone; # p < 0.05, ## p < 0.01 versus the d ‐gal‐treated WT mice group alone (n = 5–6). (F–H) Representative micrographs showing renal expression of fibronectin and Sirius red staining in different groups. Paraffin‐embedded kidney sections were stained with Sirius red and were immunostained with an antibody against fibronectin. Arrows indicate positive staining. Scale bar, 50 μm. Quantitative data showing quantification of positive staining of fibronectin (G) and fibrotic area (H). ** p < 0.01, *** p < 0.001 versus the WT mice group alone; ## p < 0.01, ### p < 0.001versus the d ‐gal‐treated WT mice group alone (n = 5–6)

Article Snippet: The expression of CB2 was assayed by fluorescence staining using a Fluorescence in situ hybridization kit (MK2530‐m; Boster technology).

Techniques: Western Blot, Expressing, Staining

CB2 induces mitochondrial dysfunction and cellular senescence in vitro. (A–I) Representative Western blot and quantitative data showing the expression of CB2, PGC‐1α, Cytb, TOMM20, COX1, COX2, p16 INK4A , γH2AX in HKC‐8 cells. HKC‐8 cells were transfected with CB2 expression plasmid (pCMV‐CB2) for 24 h. * p < 0.05, ** p < 0.01 versus the pcDNA3 group (n = 3). (J–T) Representative Western blot and quantitative data showing the expression of CB2, PGC‐1α, Cytb, TOMM20, COX1, COX2, TFAM, p16 INK4A , γH2AX and p14 ARF in HKC‐8 cells. HKC‐8 cells were treated with AM1241 (10 μM) for 48h. * p < 0.05, ** p < 0.01 versus the control group (n = 3)

Journal: Journal of Cellular and Molecular Medicine

Article Title: Cannabinoid receptor 2 plays a central role in renal tubular mitochondrial dysfunction and kidney ageing

doi: 10.1111/jcmm.16857

Figure Lengend Snippet: CB2 induces mitochondrial dysfunction and cellular senescence in vitro. (A–I) Representative Western blot and quantitative data showing the expression of CB2, PGC‐1α, Cytb, TOMM20, COX1, COX2, p16 INK4A , γH2AX in HKC‐8 cells. HKC‐8 cells were transfected with CB2 expression plasmid (pCMV‐CB2) for 24 h. * p < 0.05, ** p < 0.01 versus the pcDNA3 group (n = 3). (J–T) Representative Western blot and quantitative data showing the expression of CB2, PGC‐1α, Cytb, TOMM20, COX1, COX2, TFAM, p16 INK4A , γH2AX and p14 ARF in HKC‐8 cells. HKC‐8 cells were treated with AM1241 (10 μM) for 48h. * p < 0.05, ** p < 0.01 versus the control group (n = 3)

Article Snippet: The expression of CB2 was assayed by fluorescence staining using a Fluorescence in situ hybridization kit (MK2530‐m; Boster technology).

Techniques: In Vitro, Western Blot, Expressing, Transfection, Plasmid Preparation, Control

β‐catenin plays a mediative role in CB2‐induced mitochondrial dysfunction and cellular senescence. (A–E) Representative Western blot (A, F) and quantitative data (C–E, G and H) showing the expression of COX1, TFAM, TOMM20, p14 ARF and γH2AX in HKC‐8 cells. HKC‐8 cells were treated with AM1241 (10 μM) for 48 h and pretreated with XL‐001 (10 μM) for 1 h. Quantitative data graph (B) showing the production of adenosine triphosphate (ATP) in HKC‐8 cells. * p < 0.05, ** p < 0.01, *** p < 0.001 versus the control group alone; # p < 0.05, ## p < 0.01, ### p < 0.001versus the AM1241 group alone (n = 3). (I–N) Representative Western blot (I, M) and quantitative data (J–L, N) showing the expression of PGC‐1α, Cytb, TOMM20 and p16 INK4A in HKC‐8 cells. HKC‐8 cells were transfected with CB2 expression plasmid (pCMV‐CB2), followed by the stimulation of ICG‐001 at 10μM for 24 h * p < 0.05, ** p < 0.01, *** p < 0.001 versus the control group alone; # p < 0.05, ## p < 0.01versus the pCMV‐CB2 group alone (n = 3)

Journal: Journal of Cellular and Molecular Medicine

Article Title: Cannabinoid receptor 2 plays a central role in renal tubular mitochondrial dysfunction and kidney ageing

doi: 10.1111/jcmm.16857

Figure Lengend Snippet: β‐catenin plays a mediative role in CB2‐induced mitochondrial dysfunction and cellular senescence. (A–E) Representative Western blot (A, F) and quantitative data (C–E, G and H) showing the expression of COX1, TFAM, TOMM20, p14 ARF and γH2AX in HKC‐8 cells. HKC‐8 cells were treated with AM1241 (10 μM) for 48 h and pretreated with XL‐001 (10 μM) for 1 h. Quantitative data graph (B) showing the production of adenosine triphosphate (ATP) in HKC‐8 cells. * p < 0.05, ** p < 0.01, *** p < 0.001 versus the control group alone; # p < 0.05, ## p < 0.01, ### p < 0.001versus the AM1241 group alone (n = 3). (I–N) Representative Western blot (I, M) and quantitative data (J–L, N) showing the expression of PGC‐1α, Cytb, TOMM20 and p16 INK4A in HKC‐8 cells. HKC‐8 cells were transfected with CB2 expression plasmid (pCMV‐CB2), followed by the stimulation of ICG‐001 at 10μM for 24 h * p < 0.05, ** p < 0.01, *** p < 0.001 versus the control group alone; # p < 0.05, ## p < 0.01versus the pCMV‐CB2 group alone (n = 3)

Article Snippet: The expression of CB2 was assayed by fluorescence staining using a Fluorescence in situ hybridization kit (MK2530‐m; Boster technology).

Techniques: Western Blot, Expressing, Control, Transfection, Plasmid Preparation

CB2 plays a central role in the accelerated ageing in renal tubular cells. (A–H) Representative Western blot and quantitative data showing the expression of CB2, PGC‐1α, TOMM20, COX1, p16 INK4A , p14 ARF and β‐catenin in HKC‐8 cells. HKC‐8 cells were treated with D‐gal at 10mg/ml for 72h and pretreated with XL‐001 (10μM) for 1 h. * p < 0.05, ** p < 0.01, *** p < 0.001 versus the control group alone; # p < 0.05, ## p < 0.01, ### p < 0.001 versus the d ‐gal group alone (n = 3). (I and J) Representative micrographs and quantitative data showing SA‐β‐gal activity in different groups. Frozen kidney sections were stained for SA‐β‐gal activity. Arrows indicate positive staining. Scale bar, 20 μm. *** p < 0.001 versus the control group alone; ### p < 0.001 versus the d ‐gal group alone (n = 3). (K–N) Representative Western blot and quantitative data showing renal expression of PGC‐1α, TOMM20 and p14 ARF in HKC‐8 cells. HKC‐8 cells were treated with D‐gal at 10mg/ml or cotreated with AM1241 (10 μM) for 72 h and pretreated with ICG‐001 (10 μM) for 1 h. * p < 0.05, ** p < 0.01, *** p < 0.001 versus the control group alone; # p < 0.05, ## p < 0.01, ### p < 0.001 versus the d ‐gal group alone; †† p < 0.01, ††† p < 0.001 versus the d ‐gal+AM1241 group alone (n = 3). (O and P) Representative micrographs and quantitative data showing SA‐β‐gal activity in different groups. Frozen kidney sections were stained for SA‐β‐gal activity. Arrows indicate positive staining. Scale bar, 20 μm. ** p < 0.01 versus the control group alone; ### p < 0.001 versus the d ‐gal group alone; ††† p < 0.001 versus the d ‐gal+AM1241 group alone (n = 3)

Journal: Journal of Cellular and Molecular Medicine

Article Title: Cannabinoid receptor 2 plays a central role in renal tubular mitochondrial dysfunction and kidney ageing

doi: 10.1111/jcmm.16857

Figure Lengend Snippet: CB2 plays a central role in the accelerated ageing in renal tubular cells. (A–H) Representative Western blot and quantitative data showing the expression of CB2, PGC‐1α, TOMM20, COX1, p16 INK4A , p14 ARF and β‐catenin in HKC‐8 cells. HKC‐8 cells were treated with D‐gal at 10mg/ml for 72h and pretreated with XL‐001 (10μM) for 1 h. * p < 0.05, ** p < 0.01, *** p < 0.001 versus the control group alone; # p < 0.05, ## p < 0.01, ### p < 0.001 versus the d ‐gal group alone (n = 3). (I and J) Representative micrographs and quantitative data showing SA‐β‐gal activity in different groups. Frozen kidney sections were stained for SA‐β‐gal activity. Arrows indicate positive staining. Scale bar, 20 μm. *** p < 0.001 versus the control group alone; ### p < 0.001 versus the d ‐gal group alone (n = 3). (K–N) Representative Western blot and quantitative data showing renal expression of PGC‐1α, TOMM20 and p14 ARF in HKC‐8 cells. HKC‐8 cells were treated with D‐gal at 10mg/ml or cotreated with AM1241 (10 μM) for 72 h and pretreated with ICG‐001 (10 μM) for 1 h. * p < 0.05, ** p < 0.01, *** p < 0.001 versus the control group alone; # p < 0.05, ## p < 0.01, ### p < 0.001 versus the d ‐gal group alone; †† p < 0.01, ††† p < 0.001 versus the d ‐gal+AM1241 group alone (n = 3). (O and P) Representative micrographs and quantitative data showing SA‐β‐gal activity in different groups. Frozen kidney sections were stained for SA‐β‐gal activity. Arrows indicate positive staining. Scale bar, 20 μm. ** p < 0.01 versus the control group alone; ### p < 0.001 versus the d ‐gal group alone; ††† p < 0.001 versus the d ‐gal+AM1241 group alone (n = 3)

Article Snippet: The expression of CB2 was assayed by fluorescence staining using a Fluorescence in situ hybridization kit (MK2530‐m; Boster technology).

Techniques: Western Blot, Expressing, Control, Activity Assay, Staining

Effect of ZnONPs on aorta contractility. ( a ) Effect of ACPA (CB 1 receptor agonist) on contraction in aortic rings in different experimental groups. ( b ) Effect of HU308 (CB 2 receptor agonist) on contraction in aortic rings in different experimental groups. Blue bars correspond to the control non-treated group, green bars correspond to the ZnONPs treated-groups at different times; ( a ) there is a significant difference compared to the phenylephrine group with p < 0.05; ( b ) there is a significant difference compared to the control group with p < 0.05.

Journal: Nanomaterials

Article Title: ZnO Nanoparticles Induce Dyslipidemia and Atherosclerotic Lesions Leading to Changes in Vascular Contractility and Cannabinoid Receptors Expression as Well as Increased Blood Pressure

doi: 10.3390/nano11092319

Figure Lengend Snippet: Effect of ZnONPs on aorta contractility. ( a ) Effect of ACPA (CB 1 receptor agonist) on contraction in aortic rings in different experimental groups. ( b ) Effect of HU308 (CB 2 receptor agonist) on contraction in aortic rings in different experimental groups. Blue bars correspond to the control non-treated group, green bars correspond to the ZnONPs treated-groups at different times; ( a ) there is a significant difference compared to the phenylephrine group with p < 0.05; ( b ) there is a significant difference compared to the control group with p < 0.05.

Article Snippet: Next, aorta sections were blocked (Animal-free blocker and diluent, Vector laboratories Inc., Burlingame, CA, USA) and incubated with rabbit polyclonal Anti-CB 1 (1:100, Alomone, Labs, Jerusalem, Israel) or rabbit polyclonal Anti-CB 2 (1:100, Alomone, Labs, Jerusalem, Israel) primary antibody and co-labeled with mouse monoclonal Anti-alpha smooth muscle Actin antibody (1:200, Abcam, Cambrige, UK) overnight.

Techniques:

Effect of ZnONPs on the CB 1 and CB 2 receptors expression in the aorta wall. ( a ) CB 1 expression, ( b ) CB 2 expression. Blue bars correspond to the control non-treated group, green bars correspond to the ZnONPs treated-groups at different times; ( a ) there is a significant difference compared to the control group with p < 0.05.

Journal: Nanomaterials

Article Title: ZnO Nanoparticles Induce Dyslipidemia and Atherosclerotic Lesions Leading to Changes in Vascular Contractility and Cannabinoid Receptors Expression as Well as Increased Blood Pressure

doi: 10.3390/nano11092319

Figure Lengend Snippet: Effect of ZnONPs on the CB 1 and CB 2 receptors expression in the aorta wall. ( a ) CB 1 expression, ( b ) CB 2 expression. Blue bars correspond to the control non-treated group, green bars correspond to the ZnONPs treated-groups at different times; ( a ) there is a significant difference compared to the control group with p < 0.05.

Article Snippet: Next, aorta sections were blocked (Animal-free blocker and diluent, Vector laboratories Inc., Burlingame, CA, USA) and incubated with rabbit polyclonal Anti-CB 1 (1:100, Alomone, Labs, Jerusalem, Israel) or rabbit polyclonal Anti-CB 2 (1:100, Alomone, Labs, Jerusalem, Israel) primary antibody and co-labeled with mouse monoclonal Anti-alpha smooth muscle Actin antibody (1:200, Abcam, Cambrige, UK) overnight.

Techniques: Expressing

Representative images showed ZnONPs effect on CB 1 and CB 2 receptors expression in aorta wall. Transmitted light images (grey). Scale bar corresponds to 50 μm. Smooth muscle α-actin was detected with a specific antibody labeled with Alexa Fluor 568 (red). CB 1 and CB 2 located on the aorta ring were detected by specific antibodies and labeled with FITC (green). Image overlap indicates a high degree of colocalization of CB 1 or CB 2, and smooth muscle α-actin (yellow). Nuclei were counterstained with DAPI dye (blue).

Journal: Nanomaterials

Article Title: ZnO Nanoparticles Induce Dyslipidemia and Atherosclerotic Lesions Leading to Changes in Vascular Contractility and Cannabinoid Receptors Expression as Well as Increased Blood Pressure

doi: 10.3390/nano11092319

Figure Lengend Snippet: Representative images showed ZnONPs effect on CB 1 and CB 2 receptors expression in aorta wall. Transmitted light images (grey). Scale bar corresponds to 50 μm. Smooth muscle α-actin was detected with a specific antibody labeled with Alexa Fluor 568 (red). CB 1 and CB 2 located on the aorta ring were detected by specific antibodies and labeled with FITC (green). Image overlap indicates a high degree of colocalization of CB 1 or CB 2, and smooth muscle α-actin (yellow). Nuclei were counterstained with DAPI dye (blue).

Article Snippet: Next, aorta sections were blocked (Animal-free blocker and diluent, Vector laboratories Inc., Burlingame, CA, USA) and incubated with rabbit polyclonal Anti-CB 1 (1:100, Alomone, Labs, Jerusalem, Israel) or rabbit polyclonal Anti-CB 2 (1:100, Alomone, Labs, Jerusalem, Israel) primary antibody and co-labeled with mouse monoclonal Anti-alpha smooth muscle Actin antibody (1:200, Abcam, Cambrige, UK) overnight.

Techniques: Expressing, Labeling

Δ 9 -THC toxicity in HL-1 cells involves cytoplasmic vacuolization. (A) Δ 9 -THC and/or ethanol decreases cell viability. HL-1 cells were treated with the indicated concentrations of Δ 9 -THC and/or ethanol for 48 h. Cellular viabilities were determined by modified MTT assay. Mean cell viability of control cells [Δ 9 -THC (-), ethanol (-)] was set to 100 %, and relative cell viabilities of Δ 9 -THC and/or ethanol treated cells are shown [mean ± S.D. (n = 6); **, p < 0.01]. (B) Cells were treated with the indicated concentrations of Δ 9 -THC and/or ethanol for 48 h and observed under light microscopy. (C) Δ 9 -THC toxicity is not ameliorated by CB-R1/2 antagonists. Cells were pretreated with 1 μM AM630 or 1 μM AM251 for 1 h and further treated with the indicated concentrations of Δ 9 -THC and/or ethanol for 48 h. Graph shows the result of modified MTT assay [mean ± S.D. (n = 6); **, p < 0.01 versus untreated group].

Journal: Toxicology Reports

Article Title: Possible roles of AMPK and macropinocytosis in the defense responses against Δ 9 -THC toxicity on HL-1 cardiomyocytes

doi: 10.1016/j.toxrep.2021.04.014

Figure Lengend Snippet: Δ 9 -THC toxicity in HL-1 cells involves cytoplasmic vacuolization. (A) Δ 9 -THC and/or ethanol decreases cell viability. HL-1 cells were treated with the indicated concentrations of Δ 9 -THC and/or ethanol for 48 h. Cellular viabilities were determined by modified MTT assay. Mean cell viability of control cells [Δ 9 -THC (-), ethanol (-)] was set to 100 %, and relative cell viabilities of Δ 9 -THC and/or ethanol treated cells are shown [mean ± S.D. (n = 6); **, p < 0.01]. (B) Cells were treated with the indicated concentrations of Δ 9 -THC and/or ethanol for 48 h and observed under light microscopy. (C) Δ 9 -THC toxicity is not ameliorated by CB-R1/2 antagonists. Cells were pretreated with 1 μM AM630 or 1 μM AM251 for 1 h and further treated with the indicated concentrations of Δ 9 -THC and/or ethanol for 48 h. Graph shows the result of modified MTT assay [mean ± S.D. (n = 6); **, p < 0.01 versus untreated group].

Article Snippet: Ethanol, AM251, and AM630 were purchased from FUJIFILM Wako Pure Chemical.

Techniques: Modification, MTT Assay, Light Microscopy